Podocytic PKC-Alpha Is Regulated in Murine and Human Diabetes and Mediates Nephrin Endocytosis by Tossidou, Irini et al.
Podocytic PKC-Alpha Is Regulated in Murine and Human
Diabetes and Mediates Nephrin Endocytosis
Irini Tossidou
1, Beina Teng
1, Jan Menne
1, Nelli Shushakova
1, Joon-Keun Park
1, Jan U. Becker
2, Friedrich
Modde
2, Michael Leitges
1,3, Hermann Haller
1, Mario Schiffer
1*
1Division of Nephrology, Department of Medicine, Hannover Medical School, Hannover, Germany, 2Department of Pathology, Hannover Medical School, Hannover,
Germany, 3The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway
Abstract
Background: Microalbuminuria is an early lesion during the development of diabetic nephropathy. The loss of high
molecular weight proteins in the urine is usually associated with decreased expression of slit diaphragm proteins. Nephrin, is
the major component of the glomerular slit diaphragm and loss of nephrin has been well described in rodent models of
experimental diabetes as well as in human diabetic nephropathy.
Methodology/Principal Findings: In this manuscript we analyzed the role of PKC-alpha (PKCa) on endocytosis of nephrin in
podocytes. We found that treatment of diabetic mice with a PKCa-inhibitor (GO ¨6976) leads to preserved nephrin expression
and reduced proteinuria. In vitro, we found that high glucose stimulation would induce PKCa protein expression in murine
and human podocytes. We can demonstrate that PKCa mediates nephrin endocytosis in podocytes and that overexpression
of PKCa leads to an augmented endocytosis response. After PKC-activation, we demonstrate an inducible association of
PKCa, PICK1 and nephrin in podocytes. Moreover, we can demonstrate a strong induction of PKCa in podocytes of patients
with diabetic nephropathy.
Conclusions/Significance: We therefore conclude that activation of PKCa is a pathomechanistic key event during the
development of diabetic nephropathy. PKCa is involved in reduction of nephrin surface expression and therefore PKCa
inhibition might be a novel target molecule for anti-proteinuric therapy.
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Introduction
The activation of protein kinase C (PKC) in the kidney is a well
known pathway of the diabetic milieu. However the influence and
function of PKC on podocyte actions has so far not been studied
systematically. The 10 PKC family members are products of
distinct genes and differ in their biochemical properties, tissue
specific expression and intracellular localization [1]. PKCs are
stimulated in response to cytokines as well as various stressors
including osmotic stress and high glucose [2]. PKCs can be
subclassified into three groups: The conventional isoforms (PKCa,
bI, bII and c) require a lipid cofactor (phosphatidylserine (PS),
Ca
2+ or 1,2-diacylglycerol (DAG)) for activation; the novel
isoforms (PKCd, e, g, h, m) are Ca
2+ independent and the atypical
isoforms (PKCi/l and f) require only PS [3]. With the exception
of the atypical PKC-isoform, PKCi/l [4], the isoform-specific
knockout does not lead to a distinct renal phenotype, however in
conditions with aberrant PKC-activation, such as diabetes or
unilateral ureteric obstruction, the role of different PKC-isoforms
becomes apparent. We previously described that PKCa deficient
mice show a better outcome after streptozotocin (STZ) induced
diabetes with less proteinuria and preserved nephrin expression
[5,6]. To study the involvement of PKCa in proteinuria
development in diabetic nephropathy, we treated mice after
streptozotocin induced diabetes with a synthetic PKCa inhibitor
(GO ¨ 6976), which could prevent proteinuria development and led
to preserved nephrin expression. Biochemical analysis in wildtype
and PKCa deficient podocyte lines revealed a central role for
PKCa in endocytosis of the slit diaphragm component nephrin.
This endocytosis mediation could account for the preserved
nephrin expression in vivo. Since we observed increased expression
of PKCa in podocytes in renal biopsies of patients with diabetic
nephropathy we conclude that PKCa inhibition might be a useful
therapeutic option to prevent proteinuria development.
Materials and Methods
Ethics Statement
Animal work was conducted according to the guidelines of the
American Physiologic Society and was approved by Institutional
Animal Care and Use Committee of Hannover Medical School
and the animal welfare authorities of lower saxony. All efforts were
made to minimize the number of animals used and their suffering.
The mice received a standard diet with free access to tap water.
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Renal tissue was obtained from the archives of the
Department of Pathology, Hannover Medical School. Paraf-
fin-embedded specimens of normal kidney from nephrectomies
performed for tumor, and renal biopsy samples from adults with
diabetic nephropathy were included in this study. Renal biopsies
were used in accordance with the ethical standards of the
Hannover Medical School and with the declaration of Helsinki
of 1975, as revised in 1983. All patients consented at hospital
admission to experiments on their anonymized archived tissue
samples.
Type I diabetes model
Type I diabetes was induced in 8-week-old SV129 male mice
obtained from Charles River Laboratories (Sulzfeld, Germany)
by intraperitoneal injection of streptozotozin (STZ) (Sigma-
Aldrich, St Louis, MO) at 125 mg/kg/day in 50 mmol/l
sodium citrate puffer (pH 4.5) on days 1 and 4. The blood
glucose level was measured with the Glucometer Elite (Bayer,
Leverkusen, Germany) every other day. Approximately 80 % of
the animals were diabetic 14 days after the first injection. Only
animals which have stable blood glucose level more than
15 mmol/l and no loss of weight more than 20% within the first
days after onset of diabetes were used for following experiments.
The plasma glucose level was measured further once weekly.
The diabetic mice were distributed into two groups (n=23 per
group). One group of diabetic mice was treated daily with
GO ¨ 6976 (LC Laboratories, Woburn, Massachusetts) in dose
100 mg/8 ml DMSO subcutaneously, the second group was
injected daily with 8 ml DMSO alone. Group of nondiabetic
mice (n=16) at 8 weeks of age were assessed for blood glucose
a n da l b u m i n u r i aa n ds e r v e da sc o n t r o l s .
Albuminuria
Animals were placed in metabolic cages for 24-hour urine
collection. Albumin concentration in appropriately diluted urine
samples was measured using the Albuwell M Assay Kit (Ex-
ocel, Philadelphia, PA, USA) according to the manufacturer’s
instructions.
Statistics
Data are shown as mean 6 SD and were compared by Student’s
t-test. Data analysis was performed using Excel statistical software.
The data for albumin excretion were compared by ANOVA, and
the Bonferroni multiple comparison test was used as posttest. Data
analysis was performed using InStat. Significant differences were
accepted when P,0.05.
Antibodies and Inhibitors
Antibodies that were used for Western blotting, immuno-
histochemical and immunofluorescence studies were: rabbit
anti-PKCa,r a b b i ta n t i - b-tubulin, rabbit anti-PICK1 (Santa
Cruz Biotechnology, Santa Cruz, CA), guinea pig polyclonal
anti-nephrin (for immunohisto c h e m i c a ls t u d i e s )( P R O G E N ,
Heidelberg, Germany), ectodomain rabbit anti-nephrin (for
endocytosis assays) (Santa Cruz Biotechnology, Santa Cruz,
CA) goat anti-podocalyxin (R&D, Minneapolis, USA, ), rabbit
anti-flag, rabbit anti-myc, rabbit anti-GFP (Cell Signaling
Technology, Beverly, MA USA), mouse anti-V5 antibody
(Serotec, Kidlington, UK), Alexa Fluor 568 goat anti-guinea
pig IgG (Invitrogen, Carlsbad, CA, USA). The used PKC
inhibitor was the PKCa-inhibitor (GO ¨ 6976) (Calbiochem,
Merck, Darmstadt, Germany).
Isolation of glomeruli, establishment of conditionally
immortalized murine podocyte cell lines and podocyte
culture
Targeted disruption and generation of PKCa-deficient homo-
zygous mice on a SV129 background is described elsewhere [7].
PKCa-deficient mice were crossed to immorto mice (in BL6/C57
background) and used for generation of immortalized cell lines.
Isolation of glomeruli and establishment of PKCa deficient murine
podocyte lines was described earlier [8]. Every experimental setup
and result was confirmed in 3 different clones of PKCa+/+ and
PKCa2/2 podocytes. Continuous cultivation of conditionally
immortalized mouse podocytes was performed as described by
Mundel et al. 1996 [9].
Western Blot Analysis
To analyze whole cell protein lysates from cultured podocytes,
either untreated or treated cells were lysed on ice in RIPA buffer
(50 mM Tris pH 7.5, 150 mM NaCl, 0.5 % sodium deoxycholate,
1 % Nonidet P-40, 0.1 % SDS) containing protease inhibitor
(Complete mini, Roche, Mannheim, Germany), 1 mM sodium
orthovanadate, 50 mM NaF and 200 mg/L okadaic acid. Lysates
were centrifuged at 12,000 rpm and aliquots of the supernatants
were seperated by 10 % SDS-PAGE and transferred to PVDF
membrane (Immobilon-P, Millipore, Bedford, MA, USA). After
probing with primary antibodies antigen-antibody complexes were
detected with horseradish peroxidase-labeled anti-rabbit and anti-
mouse antibodies, respectively, and visualized using enhanced
chemiluminescence reagents (Pierce, Rockford, IL, USA) accord-
ing to the manufacturer’s protocol.
Quantitative PCR (Q-PCR) analysis of cultured cells
Total RNA was prepared from cultured human or murine
podocytes using the RNeasyHMiniKit (Qiagen, Hilden, Germany)
following the protocol recommended by the manufacturer with an
additional step of DNAse digestion (RNase-Free DNase Set;
Qiagen). One microgram of total RNA was reverse transcribed
using Oligo (dT) 15 and random primers and M-MLV Reverse
Transcriptase (Promega, Mannheim, Germany). Quantitative
PCR (qPCR) was performed on a Light Cycler 480 (Roche,
Mannheim, Germany). The cDNA was amplified using Fast Start
Taq Polymerase (Roche Diagnostics, Mannheim Germany),
SYBR Green (Molecular probes, Eugene, OR), gene specific
primers and the following PCR conditions: 5 min at 95uC, 45
cycles for 10 s at 95uC, 10 s at 60uC and 10 s at 72uC. Specifity of
the amplification product was verified by melting curve analysis.
The samples were measured as multiplexed reactions and
normalized to the constitutive gene human Hypoxanthin-Phos-
phoribosyl Transferase 1 (HPRT-1). All primers for the listed
transcripts were designed using Primer3 software: mPKCa left:
AGA ACA GGG AGA TCC AAC CA, mPKCa right: CAA AGT
TTT CTG CTC CTT TGC, hPKCa left: ACC ATT CAA GCC
CAA AGT GT, hPKCa right: GGC TGT CCT CGT GTG
TGA AGA, mNephrin left: GGG GAC CCC TCT ATG ATG A,
mNephrin right: TGG GTC CTC ATA TTT GAC CTC,
hNephrin left AGG AGC CAT AGG GAA TGG AC, hNephrin
right: GCA GAC GGA GCC TTC TTG T.
Laser microdissection of paraffin embedded tissue,
mRNA extraction and Q-PCR
Formalin fixed and paraffin embedded renal biopsies were cut
into 4-mm sections. 60 glomeruli of each specimen (n=5 controls
and n=5 with DN) were micro dissected on a mmi CellCut Plus
System (Olympus, Hamburg, Germany) without prior deparaffi-
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in 50 mL of 20 mg/mL Proteinase K solution (Merck, Darmstadt,
Germany), 50 mL of RNA digestion solution (4.2 M guanidinium
thiocyanate, 30 mM Tris-HCl of pH 7.6, and 2% sodium N-
lauroylsarcosine), and 0.5 mL of 2-mercaptoethanol at 55uC over
night immediately. Then 10 mL of 3 M sodium acetate (pH 5.2),
63 mL of Roti-Aqua-Phenol (Roth, Karlsruhe, Germany), and
27 mL of chloroform were added to precipitate RNA. After phase
separation through centrifugation, the aqueous phase (95 mL) was
carefully removed and added to 96 mL of 2-propanol and 1 mLo f
glycogen (20 mg/mL; Roche, Mannheim, Germany) as precipi-
tation carrier. The precipitated RNA was then stored at 220uC.
cDNA synthesis was performed for 2 hours at 37uC as prescribed
in the kit manual of the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Massachusetts, USA).
cDNA was then pre-amplified using TaqManH PreAmp Master
Mix (26) (Applied Biosystems, Massachusetts, USA) according to
the manual of the manufacturer. Primer pool used for pre-
amplification consisted of 6 TaqManH Assays (Applied Biosystems,
Massachusetts, USA), including PKC-alpha, WT1 and two
housekeeping genes (b-Gus, and Polymerase R2A). 25 mLo f
TaqManH PreAmp Master Mix as well as 12,5 mL of the assay
pool were added to 12,5 mL of cDNA and subjected to the
following thermocycler program: 95uC for 10 minutes, 14 cycles of
95uC for 15 seconds and 60uC for 4 minutes. Pre-amplified cDNA
was stored at 220uC. 5 mL of the pre-amplified cDNA (1:10
dilution) were added to 15 mL of master mix consisting of 10 mLo f
Gene Expression Master Mix (Applied Biosystems, Massachusetts,
USA), 4 mL of purified water and 1 mL of the respective TaqManH
Gene Expression Assay (Applied Biosystems, Massachusetts,
USA). RT-PCR primers were used to amplify PKC-alpha
(Hs00176973_m1), WT1 (Hs 01103751_m1), POLR2A (Hs
00172187_m1) and GUS B (Hs 99999908_m1). RT-PCR was
performed with a 7500 Fast Real-Time PCR System (Applied
Biosystems, Massachusetts, USA). Results are given as relative
expression levels.
Transfection
The day before transfection HEK 293T cells were seeded on
24-well plates for endocytosis assays or on 10 cm-dishes for
immunoprecipitation assay. Cells were transfected using Fugene
HD transfection reagent (Roche Diagnostics, Mannheim, Ger-
many) according to the manufacturer’s protocol. After transfection
cells were cultured in normal growth medium for 48 h.
Immunoprecipitation
HEK 293T cells were transfected like mentioned above. Then
the cells were washed carefully with ice-cold PBS on ice. For lysis
900 ml RIPA buffer were added to the cells. The lysate was
incubated for 15 min on ice and centrifuged at 14.000 rpm for
15 min at 4uC. 50 ml Flag-beads (50% slurry in Triton buffer)
(Sigma, St. Louis, USA) were added to the supernatant and
rotated overhead at 4uC for 1 h (up to overnight). After that the
beads were centrifuged at 3000 rpm for 1 min at 4uC and washed
with RIPA-buffer 5 times. Proteins were eluted by boiling the
beads in Laemmli-buffer and separated by SDS polyacrylamide
gel electrophoresis. Western blot was performed using the methods
mentioned above. For IP-Assay of podocytes 500 mg total cell
lysate was incubated with 2 mg anti-nephrin or anti-PICK1
antibody /ml IP-Volume and sepharose-A beads in IP-buffer
(25 mM Tris-HCL, pH 7.5, 1 mM DTT, 30 mM MgCL2,
40 mM NaCL, 0,5% NP-40 and protease inhibitors) overnight
at 4uC. The pellets were washed in IP-buffer (three washing steps
in total). The protein was eluated by boiling the beads in Laemmli
buffer. Lysates and elutes are analyzed by SDS polyacrylamide gel
electrophoresis.
Immunocytofluorescence-based Endocytosis Assay
For internalization studies, cells were plated in 24-wells on glass
slides and differentiated for 10 days. Cells were cooled down at
4uC and incubated with the raft-mediated endocytosis marker
Cholera toxin subunit B (Alexa Fluor 488 conjugated) (Invitrogen,
Eugene, Oregon, USA) and simultaneously with an ectodomain
anti-nephrin antibody and Cy3-conjugated secondary antibody for
1 h in RPMI without FCS at 4uC. After three washes with PBS
cells were incubated for 20 min at 4uCo r3 7 uC to induce
internalization before fixing them with 4% paraformaldehyde.
The pictures were taken with an Inverted-2 Confocal Microscope
and Leica Application Suite Software (Leica, Bonn, Germany).
Post processing was done with Photo Shop 6.0.
ELISA-based Endocytosis Assay
HEK 293T cells were transfected with constructs (mNephrin-
flag, hNephrin-SV5, pGFP-N1, PKCa-GFP) using the FUGENE-
Reagent (Roche, Mannheim, Germany). 24-well plate was coated
with poly-L-lysine 1:1 diluted with H2O (Sigma P4707 0,01%
Solution, Steinheim, Germany) and incubated overnight at 37uC.
The next day the plate was washed once with PBS and transfected
HEK-293T cells (6610
5 /well) were seeded. About 30 hours after
the transfection cells were cooled on ice for 10–15 minutes. The
medium was replaced with DFH-medium (1% FCS and 20 mM
HEPES in RPMI1640) containing 1:750 mouse anti-V5 antibody
or 1:200 rabbit anti-flag antibody. The cells were incubated for
30–60 minutes at 4uC and then washed three times with cold
DFHI-medium (1% FCS and 25 mM HEPES in RPMI1640). To
induce internalization cells were incubated with warm DFHI-
medium (1%FCS and 5 mM HEPES in RPMI1640) for 20
minutes at 37uC. The cells were fixed with 3.7% PFA for 15
minutes, washed twice with PBS and kept over night at 4uC. For
blocking 2% normal goat serum (Jackson ImmunoResearch, USA)
with 0.5% Tween-20 in PBS was used for at least 30 minutes. After
washing once with PBS the cells were incubated in RPMI1640-
medium with alkaline phosphatase coupled anti-mouse or anti-
rabbit antibody (dilution 1:7.500) for 1 hour and washed three
times with PBS, each wash 5–10 minutes. The cells were then
incubated with p-Nitrophenyl Phosphate (pNPP: Sigma N2765,
Steinheim, Germany, one tablet was resuspended in 20 ml 0,1 M
glycine, 1 mM MgCl2, 1 mM ZnCl2, pH 10,4) for about 1 hour at
37uC or until the solution turned yellow. One aliquot, about
100 ml, from the reaction was transferred in a 96-well-plate and the
extinction was measured at 405 nm in a microplate reader.
Murine PKCa+/+ and PKCa2/2 and human podocytes were
differentiated for 10 days. Endocytosis of endogenous nephrin was
induced by temperature shift (20 min) or by stimulation with high
Glucose medium (30 mM). For high glucose treatment cells were
cultured for 1 hour with medium containing 30 mM D-glucose or
with medium containing normal glucose concentration supple-
mented with Mannitol as osmotic control. The cells were cooled
down at 4uC to stop endocytosis and nephrin was labeled with an
ectodomain anti-nephrin antibody. Endocytosis of nephrin was
measured by the same method as mentioned above.
Immunohistochemistry
After dissection, kidneys were washed with phosphate-buffered
saline and immediately frozen in tissue molds containing OCT
compound (Tissue Tek). For fluorescent images were collected
onto slides, blocked with 10% donkey-serum, stained with the
appropriate primary antibody followed by a Cy3-(Jackson
PKCa and Nephrin Endocytosis
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10185Immunoresearch Lab, West Grove USA) or Alexa 488- (Invitro-
gen GmbH, Karlsruhe, Germany) conjugated secondary antibody.
Sections were analyzed using a Zeiss Axioplan-2 imaging
microscope with the scientific image processing software AxioVi-
sion 4.6 (Zeiss, Jena, Germany). The human slides were stained
following a standard peroxidase staining protocol and hematoxylin
counterstain. Human renal tissue was obtained from the archives
of the Department of Pathology, Hannover Medical School.
Paraffin-embedded specimens of normal kidney from nephrecto-
mies performed for tumor (n=7), and renal biopsy samples from
adults with DN (n=10) were included in this study. All glomeruli
were scored for expression of PKCa (n=74 glomeruli for DN and
n=150 normal glomeruli). All patients with renal disease had
significant proteinuria at the time of biopsy. Renal biopsies were
used in accordance with the ethical standards of the Hannover
Medical School and with the declaration of Helsinki of 1975, as
revised in 1983.
Results
PKCa is upregulated in podocytes in experimental as well
as in human diabetic nephropathy
First, we wanted to examine whether diabetes leads to changes
in PKCa expression in mice and in patients with diabetic
nephropathy. When we stained frozen kidney cortex sections of
control mice and mice 4 weeks after STZ-induced diabetes, we
found a strong upregulation of glomerular PKCa expression
(Fig. 1A). Next to a strong upregulation in the endocapillary/
mesangial compartment, double stainings with the podocyte
marker podocalyxin revealed a strong upregulation in podocytes
in the diabetic mice (Fig. 1A). Similarly, when we stained different
biopsy samples from patients with features of diabetic nephropathy
(n=10) compared to healthy controls (n=7), we found that PKCa
staining in healthy controls is predominantly visible in the
glomerular endothelium (Fig. 1B, panel a, b), whereas podocyte
staining was absent. Strikingly, in patients with diabetic nephrop-
athy we can demonstrate an expression of PKCa in glomerular
endothelium as well as strong expression in all podocytes (Fig. 1B,
panels c,d). This clear difference was detectable in all 10 examined
patients. All podocytes displayed a strong PKCa staining, whereas
in all examined control glomeruli endothelial staining was evident,
but podocytes were rarely detected positive for PKCa. When all
glomeruli were semiquantitavely scored with a score of 1
indicating absent or moderate expression and a score of 2
indicating strong expression we could document uniformly an
average score of 1 for all examined control glomeruli and an
average score of 2 for all examined diabetic glomeruli (Fig.1B,
panel e). In addition, when we performed laser capture microscopy
and extracted mRNA from control and diabetic human glomeruli
we found a significantly increased mRNA expression of PKCa
mRNA in the diabetic glomeruli (Fig. 1B, panel f, *p,0.05). To
delineate that high concentration of D-glucose (30 mM) would
lead to podocytic upregulation of PKCa, we cultured murine and
human podocytes for up to 24 hours in the presence of 30 mM D-
glucose. We found a significantly upregulated expression of
podocytic PKCa on mRNA and protein level. In contrast,
mannitol had no significant effect on PKCa expression (Fig. 2,
panel a, b). These data indicate, that PKCa expression is
upregulated in podocytes in experimental diabetes in mice as well
as in human diabetic nephropathy. Moreover, we found in vitro
that high glucose is a strong regulator of PKCa expression in
podocytes. To exclude direct expression effects on nephrin mRNA
in murine and human podocytes we performed Q-PCR-analysis of
nephrin mRNA in both cells types during the 24 hour time course.
We could not detect a transcriptional regulation of nephrin
mRNA in both cell types in the presence of 30 mM glucose or
mannitol (Supplementary Fig. S1).
Chemical PKCa inhibition stabilizes nephrin expression
and prevents proteinuria in streptozotocin induced
diabetes in mice
Since we had previously described preserved nephrin expression
and reduced proteinuria in diabetic PKCa deficient mice we
wanted to test whether chemical inhibition of PKCa would have a
similar protective effect. Our first observation was that under
diabetic conditions the glomerular expression of nephrin is
downregulated. Strikingly, the treatment of diabetic mice with
the PKCa inhibitor GO ¨ 6976 led to preserved nephrin expression
(Fig. 3A). When we compared total protein excretion in diabetic
mice untreated or treated with GO ¨ 6976 for four weeks, we found
a significant reduction of urinary protein levels in the GO ¨ 6976
treated group (67697.1 mg/24 h, n=23) compared to untreated
diabetic mice (2346240.3/24 h, n=23, *p,0.03) (Fig. 3B). This
treatment success led us to the hypothesis, that inhibition of PKCa
would have a direct effect on nephrin expression and slit
diaphragm integrity in vivo and thus it could be of potential use
in proteinuric situations.
PKCa regulates nephrin endocytosis
Since our results so far indicated a direct protective effect of
PKCa inhibition on nephrin expression and proteinuria develop-
ment we wanted to delineate the underlying mechanisms. Nephrin
is a key component of the glomerular slit diaphragm. It is a
transmembrane protein (185–200 kDa) with a short intracellular
domain, and an extracellular domain with eight distal IgG-like
motifs. Nephrin molecules of neighbouring foot processes build a
zipper-like structure that makes up the last barrier for serum
proteins to the urine [10]. In addition, nephrin is a platform of
signaling proteins important for the integrity of the podocyte
cytoskeleton and for the activation of signaling cascades such as
PI3K/AKT and ERK1/2 that control survival pathways of the
podocyte [11]. Mutations of the nephrin gene lead to congenital
nephrotic syndrome with proteinuria and renal failure [12]. Thus
far, only little is known about the normal protein turnover of slit
diaphragm proteins. Recently, Quack et al. described a b-arrestin
mediated mechanism of nephrin endocytosis as a molecular basis
for the turnover of slit diaphragm molecules [13]. Moreover, Quin
et al. demonstrated that nephrin can be internalized via raft-
mediated endocytosis [14]. PKCa has been previously described
to regulate caveolar endocytosis [15],[16] and to be involved in
endocytosis of transmembrane receptors [17], [18]. On the basis of
the published evidence and our results it was tempting to speculate
that PKCa could be a signaling mediator to orchestrate nephrin
endocytosis in podocytes. Therefore, we performed an immuno-
fluorescence-based endocytosis assay in murine PKCa-wildtype
(PKCa+/+) and PKCa-knockout (PKCa2/2) podocytes in
culture. When we examined endocytosis of surface expressed
nephrin we could demonstrate that nephrin is endocytosed in
PKCa+/+ podocytes after 20 min temperature shift to 37uC.
Nephrin became sorted into larger vesicles and distributed from
the cell periphery to the perinuclear compartment. Furthermore,
nephrin colocalized with the raft/caveolar-mediated endocytosis
marker Cholera toxin B (Fig. 4A, panel b). In contrast to that, we
could demonstrate that nephrin endocytosis is almost absent in
PKCa+/+ podocytes in the presence of the PKCa inhibitor
GO ¨ 6976 and in PKCa2/2 podocytes (Fig. 4A, panels c and e).
The general uptake of Cholera toxin B is not inhibited by
PKCa and Nephrin Endocytosis
PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10185Figure 1. Glomerular PKCa is upregulated in mice and patients with diabetic nephropathy. (A) Immunofluorescence using an anti-PKCa
(green) and anti-podocalyxin (red) antibody on frozen kidney cortex sections of control and diabetic mice. White arrowheads in the merged panel
depict colocalization of PKCa with podocalyxin. Picture is representative for the majority of glomeruli in control and diabetic mice (n=5) in each group).
(B) Immunohistochemistry using an anti-PKCa antibody shows expression of PKCa in human biopsy samples of healthy control individual (a, b) and a
patient with diabetic nephropathy (c, d). Black arrowheads depict expression of PKCa in the glomerular endothelium and open arrowheads depict
podocytes in normal and diabetic individual (panel b, d). Bar graphs (e) summarize semiquantitative score of all glomeruli (n=74 for patients with DN
and n=150 for control cases), indicating 1 for absent or moderate or 2 for strong expression of PKCa in podocytes and mRNA expression of PKCa
isolated from control (n=300) and diabetic (n=298) human glomeruli in relation to Wt-1 mRNA expression, *p,0.05 compared by Student’s t-test (f).
doi:10.1371/journal.pone.0010185.g001
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vesicles as indicated by Cholera toxin B uptake in the presence of
GO ¨ 6976 or in the absence of PKCa is clearly visible (Fig. 4A,
panel c and e). This would indicate a partially specific effect for
nephrin endocytosis, however a similar effect on other transmem-
brane proteins cannot be excluded. To exclude non-specific
surface binding or uptake of secondary antibody we performed the
temperature shift in the absence of primary antibody and we could
not detect a significant red fluorescence signal (Supplementary Fig.
S2). So in summary, our Cholera toxin B experiments indicate a
PKCa mediated effect on nephrin endocytosis, however for a clear
differentiation of raft- or clathrin-mediated endocytosis additional
experiments would be required since Cholera toxin B cannot
clearly differentiate both endocytosis types.
Figure 2. PKCa expression is upregulated by high glucose in murine and human podocytes. Quantitative PCR (a) and Western blot
analysis (b) for PKCa in murine and human podocytes depicts induction of protein in a time course experiment after stimulation with high glucose
(30 mM) and mannitol as osmotic control for up to 24 hrs (results are representative for 3 independent experiments). Scale bars of quantitative PCR
summarizes means of high glucose (white bars) and Mannitol (black bars) of n=3 independent experiments. (*p,0.01, 0 versus 4, 8 hrs (murine) and
*p,0.05 0 versus 0.5, 1, 2 hrs (human) compared by Student’s t-test. Densitometric analysis summarizes means of PKCa and b-tubulin ratios after high
glucose (white bars) and mannitol (black bars) stimulation in n=3 independent experiments. OD was quantified using Quantity One software.
*p,0.03, 0 hrs versus 4, 8, 24 hrs (murine), *p,0.04 0 versus 0.5, 1, 2 hrs (human) compared by Student’s t-test.
doi:10.1371/journal.pone.0010185.g002
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independent assay system with a cell-based ELISA. We could
demonstrate a reduced rate of nephrin endocytosis in cultured
murine PKCa+/+ and human podocytes in the presence of
GO ¨ 6976 and in murine PKCa2/2 podocytes after temperature
shift to 37uC (Fig. 4B). Furthermore, high glucose treatment for
1 hour leads to endocytosis of nephrin in murine PKCa+/+ and
human podocytes. This effect is significantly higher compared to
high glucose treated PKCa+/+ and human podocytes in the
presence of GO ¨ 6976 and in PKCa2/2 podocytes (Fig. 4C). To
test whether PKCa overexpression would lead to an increased rate
of nephrin endocytosis we performed overexpression experiments
in HEK293T cells. In this artificial overexpression system we
could also document reduced endocytosis of overexpressed mouse
and human nephrin constructs in the presence of GO ¨ 6976.
Interestingly, we found that the simultaneous overexpression of a
PKCa-construct would lead to an enhanced nephrin endocytosis
response. This effect was partially inhibited in the presence of the
PKCa inhibitor (Fig. 4D). In addition, we could confirm these
results in PKCa+/+ and PKCa2/2 podocytes using surface
Figure 3. PKCa inhibition or deficiency preserves nephrin expression and reduces proteinuria in vivo. (A) Diabetes was induced in
SV129 mice with STZ. Immunofluorescent images show expression of nephrin (red) in control, untreated diabetic or GO ¨6976 treated diabetic mice
(pictures are representative for the majority of glomeruli in the three different groups) (scale bar upper panels 100 mm, lower panels 20 mm). (B)
Graphical summary of urinary albumin excretion in 24 hrs of control (n=16), diabetic (n=23) and diabetic mice treated with GO ¨6976 (n=23),
*p,0.03 diabetic mice versus GO ¨6976 treated diabetic mice.
doi:10.1371/journal.pone.0010185.g003
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detected a higher amount of biotinylated nephrin in PKCa2/2
podocytes indicating a higher rate of endocytosis in the wildtype
cells (Fig. 4E). To exclude non specific surface binding of the
primary antibody we performed the experiments with a mouse or
rabbit IgG control (Santa Cruz, CA, USA). To ensure that our
results in the different cell types were not influenced by reduced
cell survival during the temperature shift or transfection
procedures we used trypan blue stainings on all cell types to proof
cell viability. None of the temperature conditions would affect cell
viability in the murine and human podocyte cell lines or the
transfected HEK293T cells (Supplementary Fig. S3).
PKCa regulates nephrin endocytosis via PICK1
To understand the observation of reduced proteinuria and
preserved nephrin expression mechanistically, we investigated
whether PKCa interacts with nephrin and whether that interaction
Figure 4. PKCa promotes nephrin endocytosis. (A) PKCa+/+ (a, b, c) and PKCa2/2 (d, e, f) podocytes were double labelled with Cholera toxin-B
(green) and an ectodomain anti-nephrin antibody detected with an Cy3-labeled secondary antibody (red). The cells are labelled at 4uC and incubated
at 4uC (a, d) or shifted to 37uC (b, c, e, f) for 20 min to induce internalization in the absence (b, e) or presence of the PKCa-inhibitor GO ¨6976 (20 mM)
(c, f) (scale bars 10 mm). (B, C) Nephrin expressed at the surface of murine PKCa+/+ and PKCa2/2 and human podocytes is labelled with an anti-
nephrin antibody at 4uC. (B) For temperature shift experiments cells were left at 4uC or incubated at 37uC for 20 min in the absence or presence of the
PKCa-Inhibitor GO ¨6976 (20 mM) to induce internalization. (C) For glucose experiments murine PKCa+/+ and PKCa2/2 and human podocytes are
stimulated for 1 hour with high glucose (30 mM) or Mannitol. Endocytosis of nephrin is stopped by cooling down at 4uC and labelled with an anti-
nephrin antibody. Extinction was measured at 405 nm. Bar graphs represent the graphical summary of three independent experiments. *p,0.035,
compared by Student’s t-test for temperature shift and glucose experiments. (D) PKCa overexpression enhances nephrin endocytosis. HEK 293T cells
were transfected with mNephrin-flag or hNephrin-SV5 and PKCa-GFP, or with the empty vector GFP-N1. Nephrin expressed at the surface is labelled
with an anti-flag or anti-SV5 antibody. The cells are labelled at 4uC followed by an incubation at 37uC for 20 min in the absence or presence of the
PKCa-inhibitor GO ¨6976 (20 mM) to induce internalization. The extinction was measured at 405 nm. Bar graphs represent the graphical summary of
three independent experiments.
* P,0.002, compared by Student’s t-test. Mouse or rabbit IgG was used to exclude non specific surface binding of
the primary antibody. (E) Cell surface was biotinylated in PKCa+/+ and PKCa2/2 podocytes before and after endocytosis induction. Cells were lysed
and biotinylated proteins were precipitated using streptavidin-beads. Beads were boiled in loading buffer and western blot procedure revealed
nephrin content of biotinylated protein fraction. Lysates were analyzed for nephrin. Bar graphs show the graphical summary of two independent
experiments, (*p,0.03) compared by Student’s t-test.
doi:10.1371/journal.pone.0010185.g004
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tions we could demonstrate a PMA inducible interaction of PKCa
and murine nephrin in transfected HEK293T cells (Fig. 5A). PKCa
binds to nephrin and we detected a strong inducible interaction
within 15 minutes. A similar result was obtained when we used
human nephrin in our experiments (Supplementary Fig. S4). Since
PKCa dependent endocytosis has been described earlier in
orchestration with the PDZ- and BAR-domain-containing protein
PICK1 (protein interacting with C-kinase) [19,20], we wanted to
test whether PMA stimulation would lead to recruitment of PICK1
to this complex. Similarly to our results with PKCa,w ec o u l d
detect a PMA inducible interaction of nephrin and PICK1 (Fig. 5A).
To confirm our results on an endogenous level, we performed co-
immunoprecipitations of endogenous nephrin and endogenous
PKCa in podocytes. Similarly to our results in HEK293T cells, we
found an inducible interaction of PKCa and PICK1 within 15
minutes after stimulation with PMA (Fig. 5B) in PKCa+/+
podocytes. In contrast, no association was detectable in the
PKCa2/2 podocytes indicating an endogenous protein complex
specifically orchestrated via PKCa (Fig. 5B). In summary, our data
indicate that PKCa expression can be regulated by different
stressors in podocytes in vitro and in vivo. Specifically in the diabetic
millieu PKCa mediates nephrin endocytosis and PKCa-deficiency
or inhibition leads to preserved nephrin expression on the podocyte
surface and thus has a direct protective effect on the integrity of the
slit diaphragm.
Figure 5. Inducible interaction of transiently overexpressed and endogenous nephrin with PKCa and PICK1. (A) HEKT293T cells were
transiently transfected with mNephrin-flag, PKCa-GFP and PICK1-myc and stimulated with PMA for 0, 5 and 15 min. Nephrin-flag was precipitated
with agarose labelled with an anti-Flag-antibody. The probes were blotted and analyzed for GFP and Myc. (B) Endogenous nephrin and PICK1 were
precipitated (IP) using an anti-nephrin and anti-PICK1 antibody from whole cell lysates of PKCa+/+ and PKCa2/2 podocytes which were treated for
0, 5 and 15 min with PMA. The probes were blotted and analyzed for PKCa, nephrin and PICK1.
doi:10.1371/journal.pone.0010185.g005
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Our results provide novel mechanistic insights into the
relationship of PKCa activity and the signaling response of
podocytes under diabetic conditions. Nephrin is a single
transmembrane receptor that belongs to a family of adhesion
molecules. A genetic defect in nephrin expression leads to
congenital nephrotic syndrome [21]; [22]. Furthermore, ne-
phrin signaling contributes to the overall survival response in
podocytes and anchors important signaling molecules to the
glomerular filtration slit [11]. Nephrin molecules of neighbour-
ing foot processes built the backbone of the slit diaphragm and
together with the recently identified Neph1 it forms a hetero-
oligomeric complex in the plane of the membrane that interacts
across the foot process interaction [23], [24]. Since the blood
flow dependent changes of the glomerular capillary diameter
require constant adaptation processes, it seems likely that foot
process formation and the formation of the slit diaphragm is a
highly dynamic process with constant turnover and renewal of
these transmembrane proteins. A molecular regulation of the slit
diaphragm complex turnover via nephrin phosphorylation and
endocytosis was first described by Quack and coworkers [13]. In
this manuscript we describe PKCa as a high glucose inducible
kinase that orchestrates nephrin internalization in podocytes.
We found a significant induction of glomerular PKCa
expression in diabetic glomeruli in podocytes in mice and
humans. This stress induced glomerular induction effect in
diabetes is novel. A regulation of PKCa/b in podocytes has
previously only been documented in human membranous
nephropathy, however the conclusion of its functional role
remained elusive [25]. Strikingly, when we injected mice with a
PKCa inhibitor we observed a preserved nephrin expression
which is reflected in the urineb yas i g n i f i c a n t l yr e d u c e d
excretion of albumin. This is in line with previous observation
from our group where we detected preserved nephrin expression
and reduced proteinuria in diabetic PKCa deficient mice [5]. In
addition, we can demonstrate a glucose dependent induction of
PKCa mRNA and protein in murine and human podocytes.
Moreover, we demonstrate in different in vitro experiments
PKCa-mediated endocytosis of murine and human nephrin. Qin
and coworkers showed a raft-mediated endocytosis of nephrin [14]
This is in line with our observations where we can demonstrate
that PKCa-mediated endocytosis of nephrin is raft-mediated.
Many other studies showed that raft-mediated endocytosis by
caveolar are PKCa-regulated [15],[16]. Supporting evidence
comes from our immunoprecipitation findings, where we
demonstrate that PKCa associates with nephrin and PICK1
after PMA stimulation. Recruitment of PICK1 has been
demonstrated as a key step in PKCa mediated trafficking of
AMPA receptors via direct interaction with PKCa and the
AMPA receptor subunits GluR1-GluR4 [19] in the PDZ
domain of PICK1. This association is required for AMPA-
receptor trafficking. This inducible interaction of endogenous
nephrin and endogenous PKCa is reproducible in transient
assays as well as with endogenous proteins in podocytes. On the
background of these results we speculate that PKCa activity
contributes to the pathogenesis of proteinuria by disrupting the
glomerular filter in response to high glucose via nephrin
internalization. Absence or inhibition of PKCa leads to
stabilized surface expression of nephrin and this has positive
effects on proteinuria development. We would further hypoth-
esize that nephrin or possibly turnover of the whole slit
diaphragm complex is regulated similar as turnover and
trafficking of activated growth factor receptors [13]. This would
support the role for nephrin as a structural sensor regulating the
integrity of the slit diaphragm.
In diabetes microalbuminuria is one of the earliest detectable
abnormalities that, when left untreated, will eventually progress to
gross proteinuria. Since the degree of proteinuria correlates with
tubular interstitial fibrosis the early treatment of proteinuria and
prevention of progression to significant proteinuria levels is an
important step to delay disease progression. In the development of
diabetic glomerulopathy an increase in podocyte foot process
width and podocyte loss has been observed in a variety of patients
with diabetes [26,27]. Also, loss and downregulation of nephrin is
a well described effect in patients with diabetic nephropathy
compared to healthy controls [28].
In summary, our results open new avenues for further
investigations on slit diaphragm turnover under physiological
and pathological conditions. Furthermore, PKCa inhibition is a
promising target molecule for podocyte protective therapy in
proteinuric kidney diseases and in particular for diabetic
nephropathy.
Supporting Information
Figure S1 Podocytic nephrin mRNA expression is not altered by
high glucose treatment. Q-PCR for Nephrin in murine and
human podocytes demonstrates mRNA expression in a time
course experiment after stimulation with high glucose (30 mM)
and mannitol as osmotic control for up to 24 hrs (results are
representative for 3 independent experiments).
Found at: doi:10.1371/journal.pone.0010185.s001 (0.92 MB TIF)
Figure S2 Staining procedure with rabbit IgG. PKCa+/+
podocytes were double labelled with Cholera toxin-B (green) and
rabbit IgG followed by an Cy3-labelled secondary antibody (red)
as a negative control for unspecific binding of the primary and
secondary antibody. The cells are labelled at 4uC.
Found at: doi:10.1371/journal.pone.0010185.s002 (1.07 MB TIF)
Figure S3 Podocytes and transfected HEK 293T cells are viable
during endocytosis assay. PKCa+/+, PKCa2/2, human podo-
cytes and transfected HEK293T cells (hNephrin-SV5 and PKCa-
GFP) were cooled down at 4uC, shifted to 37uC in the absence or
presence of the PKCa inhibitor GO ¨ 6976 or permeabilized with
80% methanol as control for 10 min. Cells were stained with 0,4%
trypan blue.
Found at: doi:10.1371/journal.pone.0010185.s003 (2.89 MB TIF)
Figure S4 Inducible Interaction of transiently overexpressed
human nephrin with human PKCa. HEK293T cells were
transiently transfected with hNephrin-flag and hPKCa-GFP and
stimulated with PMA for 0, 5 and 15 min. Nephrin-flag was
precipitated with agarose labelled with an anti-Flag-antibody. The
probes were blotted and analyzed for GFP and Flag content.
Found at: doi:10.1371/journal.pone.0010185.s004 (0.94 MB TIF)
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